Tailong Pharmaceutical announced that the company held the 11th meeting of the 10th board of directors on July 24, 2026 to review and pass relevant proposals and elect Chen Siliang as the chairman of the company until the end of the term of the 10th board of directors. Since the chairman is the legal representative, the board of directors authorized the registration of industrial and commercial changes. Furthermore, it was agreed to by-elect Chen Siliang as a member of the Strategy and Development Committee of the 10th board of directors and to serve as chairman until the end of his term.

Tailong Pharmaceutical announced that the company held the 11th meeting of the 10th board of directors on July 24, 2026 to review and pass relevant proposals and elect Chen Siliang as the chairman of the company until the end of the term of the 10th board of directors. Since the chairman is the legal representative, the board of directors authorized the registration of industrial and commercial changes. Furthermore, it was agreed to by-elect Chen Siliang as a member of the Strategy and Development Committee of the 10th board of directors and to serve as chairman until the end of his term.